Larvol Delta - ACELYRIN-INC-Announces-TopLine-Results-from-PlaceboControlled-Clinical-Trial-of-Izokibep-for-ModeratetoSevere-Hidradenitis-Suppurativa

izokibep (ABY-035) - Affibody, ACELYRIN

https://www.globenewswire.com/news-release/2023/09/11/2741149/0/en/ACELYRIN-INC-Announces-Top-Line-Results-from-Placebo-Controlled-Clinical-Trial-of-Izokibep-for-Moderate-to-Severe-Hidradenitis-Suppurativa.html

Sep 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next